Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16
Closed -$2.06K 874
2023
Q2
$2.06K Hold
16
﹤0.01% 757
2023
Q1
$1.86K Hold
16
﹤0.01% 766
2022
Q4
$1.81K Sell
16
-120
-88% -$13.2K ﹤0.01% 778
2022
Q3
$11K Hold
136
0.01% 587
2022
Q2
$10.1K Buy
+136
New +$12.4K 0.01% 643
2022
Q1
Sell
-184
Closed -$25K 477
2021
Q4
$25K Sell
184
-280
-60% -$40.2K 0.02% 522
2021
Q3
$62K Buy
464
+264
+132% +$33.3K 0.03% 346
2021
Q2
$22K Buy
+200
New +$19.2K 0.02% 521

Other funds holding DXCM

Eagle Bay Advisors's DXCM Position: Q3 2023 in Review

Eagle Bay Advisors sold out of DexCom (DXCM) in Q3 2023, closing a stake of 16 shares — an estimated $2.06K sold.

Eagle Bay Advisors first reported a position in DXCM in Q2 2021 and held it in 8 quarters. The position peaked at $62K in Q3 2021. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Eagle Bay Advisors reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Eagle Bay Advisors sold 16 DexCom shares in Q3 2023, an estimated $2.06K.
  • Eagle Bay Advisors first reported a position in DexCom in Q2 2021 and held it in 8 quarters.
  • Eagle Bay Advisors's DexCom position peaked at $62K in Q3 2021.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Eagle Bay Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.